Mollet del Valles, Spain

Josep M Aran Perramon

USPTO Granted Patents = 2 

 

 

Average Co-Inventor Count = 3.4

ph-index = 1


Location History:

  • Mollet del Valles, ES (2020)
  • Barcelona, ES (2024)

Company Filing History:


Years Active: 2020-2024

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Josep M Aran Perramon: Innovator in Atherosclerosis Diagnosis

Introduction

Josep M Aran Perramon is a notable inventor based in Mollet del Valles, Spain. He has made significant contributions to the field of medical diagnostics, particularly in relation to atherosclerosis and its associated risks. His innovative work has the potential to improve patient outcomes through advanced predictive methods.

Latest Patents

Josep M Aran Perramon holds a patent for "Predictive methods of atherosclerosis and stenosis." This invention focuses on methods for diagnosing unstable atherosclerotic plaque, determining the probability of suffering from a stroke, selecting appropriate therapy for individuals with carotid artery disease, and predicting the progression of atherosclerotic disease. He has 1 patent to his name, showcasing his expertise in this critical area of healthcare.

Career Highlights

Throughout his career, Aran Perramon has worked with esteemed organizations such as the Institut d'Investigació Biomèdica de Bellvitge (IDIBELL) and the Fundació Assistencial de Mútua de Terrassa. His roles in these institutions have allowed him to collaborate with leading professionals in the field, further enhancing his research and innovation capabilities.

Collaborations

Some of his notable coworkers include Ana Luque Gómez and Jerzy Krupinski. Their collaborative efforts have contributed to the advancement of medical research and the development of innovative diagnostic methods.

Conclusion

Josep M Aran Perramon is a distinguished inventor whose work in predictive methods for atherosclerosis has the potential to transform patient care. His contributions to medical diagnostics reflect his commitment to improving health outcomes through innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…